Chaoju Ophthalmology (02219) is now up more than 5%. As of press release, it is up 5.53% to HK$4.01, with a turnover of HK$14.7673 million.
The Zhitong Finance App learned that Chaoju Ophthalmology (02219) is now up more than 5%. As of press release, it has risen 5.53% to HK$4.01, with a turnover of HK$14.7673 million.
Guoyuan International pointed out that the company's business is deeply involved in Inner Mongolia, covering North China and East China; Inner Mongolia has obvious competitive advantages and extremely high barriers, which is the basic guarantee for the steady growth of the company's performance. In September 2022, it acquired shares in Tangshan Jidong Hospital/Yutian Jidong Hospital/Luannan Jidong Hospital/Luanzhou Jidong Hospital to expand its business footprint to Hebei; through empowerment, the company achieved rapid growth in ophthalmology business in hospitals such as Tangshan and other hospitals by exporting excellent medical and management experience.
The company currently holds 1.64 billion yuan in cash, transactional financial assets and investments, and has sufficient capital for extended expansion. Continued acquisitions and new construction plans are expected in 2024-2025. The company completed the acquisition of 97% of Beijing Mingyue Ophthalmology Clinic Co., Ltd. in December 2023, at a cost of RMB 36.86 million. The establishment of Beijing Hospital is conducive to the company's collaboration of high-quality medical volunteers in Beijing, Inner Mongolia and North China, improving the quality of medical services and cultivating new growth points.